ATAnkita Tiwari

Ankita Tiwari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ankita Tiwari has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • COVID 19: Variants, Diagnosis and Vaccines- An Update

    by Parul Chauhan, Ankita Tiwari, Okoro Emmanuel, Marianesan Arockia Babu

    Introduction: In 2019, a life-threatening virus, SARS-CoV-2 emerged in China and caused destruction all around the world, affecting many lives; the origin of this virus is still debatable and unclear. The coronavirus is a contagious disease with high rates of transmission; it mutates rapidly and now has variants, some of which have caused a lot of damage to lives and the economy. Methods: These variants are mainly classified into three main groups: a) variants of concern; b) variants of interest; and c) variants under monitoring. Vaccines are the safest and most effective option for preventing COVID and saving lives, as building immunity and breaking the chain of transmission is essential even though vaccines that have been developed till now have different effects against different variants of coronavirus. Results: As it is known that vaccines are the main shield to protect from coronavirus, due to rapid mutation and slow developments of vaccines several people are still getting infected with COVID-19. Discussion: Many treatment options are available, such as antiviral drugs, nanotechnology, plasma therapy, and monoclonal antibodies. Conclusion: Besides prevention and treatment, correct diagnosis of the disease is essential, and for this purpose, different diagnostic techniques are discussed in this article alongside the possible future of COVID-19.

  • Formulation and Evaluation of Emulsion-based Herbal-Synthetic Hybrid Shampoo for Scalp Seborrheic Dermatitis

    by Ishika Arora, Kumud Madan, Bhumika Kumar, Sanjeev Kumar Patel, Ankita Tiwari

    Introduction: Scalp seborrheic dermatitis is a persistent scalp condition frequently linked to an overabundance of Malassezia yeast and is characterised by excessive oil production, dandruff, and irritation. Antifungal and anti-inflammatory drugs used in conventional therapies might cause dryness and irritation if synthetic formulations are used for extended periods. Aim: This study aimed to formulate and evaluate an emulsion-based herbal-synthetic hybrid shampoo for scalp seborrheic dermatitis. This shampoo combines the therapeutic benefits of herbal extracts with synthetic surfactants to effectively control seborrhoeic dermatitis. Materials and Methods: Different herbal extracts and synthetic APIs were incorporated into the herbal–synthetic hybrid shampoo, along with surfactants, co-surfactants, and other shampoo additives. Firstly, an emulsion was prepared using oil and aqueous phase ingredients, followed by shampoo preparation using additive ingredients. discussion: The emulsion-based herbal-synthetic hybrid shampoo had a lot of promise for treating seborrhoeic dermatitis on the scalp by working together. Adding herbs like neem, ajwain, and bitter gourd gave the product antifungal, anti-inflammatory, and relaxing characteristics. Synthetic surfactants made sure that it cleaned well. The steady oil-in-water emulsion helped the therapeutic activity by making the scalp more evenly covered and dispersed. The evaluation factors, such as the best pH (5.5–6.0), acceptable viscosity, and high foam stability, showed that the application was easy to use. In vitro tests showed that regular use resulted in less irritation, peeling, and redness. The hybrid method worked well because it combined the effectiveness of synthetic agents with the safety of herbal ingredients. However, more clinical trials and irritant studies are needed to make sure that it is safe and effective over the long term. Results: The designed shampoo had good physicochemical properties, including a thick, opaque viscosity, a potent essential oil scent, and an orange hue. As the pH (6-7) was within the range suitable for the scalp, there was less chance of discomfort. Its moderate foaming ability (4.4 cm foam height), decent cleaning action, and 21.4% washability ensured that excess oil and dandruff scales were effectively removed, leaving no residue behind. The solid content (23.57%) indicated that the active components were present in sufficient amounts for stability and effectiveness. Discussion: The herbal-synthetic hybrid shampoo exhibited favourable physicochemical properties, effective cleansing, and scalp-friendly qualities, which could make it beneficial for scalp health and treatment of seborrhoeic dermatitis. However, further in vivo examination remains necessary. Conclusion: The hybrid shampoo may prove to be a secure and efficient substitute for traditional antifungal therapies. More research is advised to increase its therapeutic value, including clinical assessments and improvements in formulation properties.

  • Association of pathologic response and survival after peri-operative therapy in resected pancreatic adenocarcinoma: KU cancer center experience.

    by Brett Rozeboom, Maximillian Martinez, Kathan Mehta, Ameer Hamza, Anusha Chidharla, Anwaar Saeed, Raed Moh'D Taiseer Al-Rajabi, Joaquina Celebre Baranda, Sean Kumer, Timothy Schmitt, et al.

    E16254 Background: Neo-adjuvant therapy (NAT) and associated pathologic complete response (pCR) rates have correlated with improved survival in resected pancreatic ductal adenocarcinoma (PDAC). In this study, we explored the relationship between pathologic response, peri-operative therapy, and survival, especially the impact of change in adjuvant therapy in patients with no/poor path response to NAT. Methods: Retrospectively reviewed 66 PDAC patients who received NAT ± radiation and underwent resection at KU Cancer Center between 2011-2022. We compared DFS and OS between Path Responders vs Non-Responders based on standard Tumor Regression Scores from pathology reports. A subanalysis was performed in path non-responders based on switch in adjuvant therapy (AT) versus not. Results: Patient characteristics are summarized in the table. Among 66 PDAC patients, 50 (75.8%) achieved a path response (G0-G2), 16 (24.2%) experienced no/poor path response (G3). Of the 50 pts who achieved a path response, 4 (8.0%) had a complete path response (pCR; G0), 5 (10%) marked response (G1), 41 (82%) moderate response (G2). Median DFS (mDFS) was 17.3 months (95% CI: 12.7-22.4) in Path Responders vs 15.9m (95% CI: 9.6-35.8) in Non-Responders [p=0.59]. Median OS (mOS) was 32.9m (95% CI: 23.4-41.5) vs 27.7m (95% CI: 15.2-38.2), respectively [p=0.39). A sub-analysis in the Non-Responders (n=16) based on switch in AT (n=8) vs not (n=3), revealed mDFS 16.4m (95% CI: 9.6-41.8) when AT was switched vs mDFS 11.3m (95% CI: 5.9-16.6) when AT was not switched [p=0.24]; and mOS 30.6m (95% CI: 15.7-60.3) vs 17.2 months (95% CI: 6.7-27.7), respectively [p=0.18]. Conclusions: Our study found no statistical difference in DFS and OS between Pathologic Responders and Non-Responders to neo-adjuvant therapy. However, a sub-analysis within Pathologic Non-Responders revealed a longer DFS and OS after switching adjuvant therapy without reaching statistical significance, likely due to small sample size. Our findings warrant validation in a larger cohort as switch in adjuvant therapy could potentially change the treatment landscape for Pathologic Non-Responders.

  • Determination of Oxaliplatin and Curcumin in Combination via Micellar HPLC and Its Method Validation

    by Ankita Tiwari, Devasish Bose, Pooja Mishra, Ankit Jain, Sanjay K Jain

    A micellar-HPLC method was developed for the determination of oxaliplatin (OHP) and curcumin (CUR) employing a C18 column [4.6 × 250 mm, particle size (dp) = 5 µm] and diode array detector. A rapid, cost-effective, environmentally friendly, time-efficient, easy-to-handle, and safe method was developed. The conditions were optimized for the estimation of OHP and CUR: 0.15 M sodium dodecyl sulfate (SDS) in 6% (v/v) pentanol buffered to pH 5.0 with a flow rate of 1.0 mL/min, injection volume of 20 µL, and detection at 325 nm. Different analytical parameters, including linearity, accuracy, precision, robustness, specificity, LOD, and LOQ, were determined in compliance with the International Council on Harmonisation (ICH) guidelines. The LOD (S/N = 3) of OHP was 0.004 µg/mL and for CUR it was 0.005 µg/mL. The calibration curves for OHP and CUR were linear over the range 0.015–10 µg/mL (determination coefficient r2 = 0.9999) and 0.015–10 µg/mL (r2 = 0.9994), respectively. The drugs were eluted in <12 min and the developed method was applicable for analyzing multiple samples per day. Moreover, it was determined to be robust and was used to quantify OHP and CUR in mice serum/blood. The method could pave the way for quantitative analysis of these drugs during the development of a pharmaceutical preparation for the treatment of colorectal cancer. A simple, cost-effective, eco-friendly HPLC method was developed to simultaneously estimate oxaliplatin and curcumin. The developed method was validated as per the ICH guidelines.


  • Opportunities in combinational chemo-immunotherapy for breast cancer using nanotechnology: an emerging landscape

    by Sarjana Raikwar, Ankit Jain, Shivani Saraf, Pooja Das Bidla, Pritish Kumar Panda, Ankita Tiwari, Amit Verma, Sanjay K. Jain

    Breast carcinoma (BC) is one of the most frequent causes of cancer-related death among women, which is due to the poor response to conventional therapy. There are several complications associated w...


  • Curcumin Based Drug Delivery Systems for Cancer Therapy

    by Ankita Tiwari, Sanjay K. Jain

    Cancer accounts for the second major cause of death globally. Conventional cancer therapies lead to systemic toxicity that forbids their long term application. Besides, tumor resistance and recurrence have been observed in the majority of cases. Thus, the development of such therapy, which will pose minimum side effects, is the need of the hour. Curcumin or diferuloylmethane (CUR) is a natural polyphenol bioactive (obtained from Curcuma longa) which possesses anti-cancer and chemo-preventive activity. It acts by modulating various components of signaling cascades that are involved in cancer cell proliferation, invasion, and apoptosis process. It interacts with the adaptive and innate immune systems of our body and causes tumor regression. This may be the reason behind the attainment of in vivo anti-tumor activity at a very low concentration. Its ease of availability, safety profile, low cost, and multifaceted role in cancer prevention and treatment has made it a promising agent for chemoprevention of many cancers. Regardless of the phenomenal properties, its clinical utility is haltered due to its low aqueous solubility, poor bioavailability, rapid metabolism, and low cellular uptake. In the last few years, a variety of novel drug carriers have been fabricated to enhance the bioavailability and pharmacokinetic profile of CUR to attain better targeting of cancer. In this review, the recent developments in the arena of nanoformulations, like liposomes, polymeric NPs, solid lipid NPs (SNPs), polymeric micelles, nanoemulsions, microspheres, nanogels, etc. in anticancer therapy have been discussed along with a brief overview of the molecular targets for CUR in cancer therapy and role of CUR in cancer immunotherapy.


  • Application Potential of Pectin in Drug Delivery

    by Pritish Kumar Panda, Gaytri Gour, Shivani Saraf, Ankita Tiwari, Amit Verma, Ankit Jain, Sanjay K. Jain

    Pectin, a naturally occurring, biodegradable heteropolysaccharides, comprised of (1,4)-linked α-d-galacturonic acid entities and numerous neutral sugars like D-galactose, L-arabinose, and D-xylose, etc., has grabbed the attention of scientists in last few years because of its biodegradability, biocompatibility, and non-toxicity. It has found promising applications in an arena of drug delivery and biomedical field. On the basis of its degree of esterification (DE), it has been classified into two major groups, i.e., low methoxy pectin (LMP) and high methoxyl pectin (HMP). The pectin chains combine to form the three-dimensional frameworks leading to the formation of a gel. The pectin properties can be enhanced and chemically altered to form composites, blends for a multiplicity of pharmaceutical applications. It has been utilized potentially as a polymer for targeted drug delivery. This chapter deals with the application potential of pectin in the development of drug delivery systems.


  • Design of a brain computer interface for stress removal using Yoga a smartphone application

    by Ankita Tiwari, Rajinder Tiwari

    In this paper there is a design application of a smart system which detects the stress directly from a human brain, as a Brain Computer Interface provides a direct channel to interface outside object or device and a living brain. This interface helps the person to send the messages or commands from his brain or it can also be said that only thought process can be performed without any muscle movement. Stress is a concept which directly affects a human brain. Electroencephalogram signals are used here for measurement of the response, generated by millions of nerve cells known as neurons. These activities can be recorded by electrodes placed on scalp. Here in this paper and idea for developing a system that is serving fruitful solution for the problem by giving a system which is smart enough to use a Yoga and Music Therapy. The only objective is to provide relaxation to the subject or person.